R&D | December 05, 2025
Industry-academia partnership key to advancing R&D agenda, says Dr. Jitendra Singh
Growing patent filings and tier-2 innovators reflect expanding national research base
Growing patent filings and tier-2 innovators reflect expanding national research base
Landmark studies have shown that rapid TXA administration can significantly reduce mortality
Netherlands site will bring 500 manufacturing and 1,500 construction jobs while further strengthening Lilly's global supply chain
Dr. Jindal reflects on bridging accessibility gaps between urban and rural regions, the ethical and emotional aspects of family building, and how initiatives like adoption facilitation centers align with his lifelong mission to help couples realize the dream of parenthood
The collaboration is expected to facilitate access to world-class treatments and specialised care for Iraqi personnel
The new Houston site, Lilly's eighth U.S. manufacturing facility announced since 2020, will focus on domestic production of small molecule synthetic medicines
This marks the first of four new U.S. manufacturing sites that Lilly plans to announce this year
Minister releases five breakthrough veterinary technologies to strengthen diagnostics and combat antimicrobial resistance
Dr. Rao has over 29 years of experience in manufacturing, R&D, business operations, and customer service
Deepak has around 25 years of work experience with reputed companies viz. UPL Group, Teva Group, AkzoNobel India, Ranbaxy Laboratories, and Dr. Reddy’s Laboratories
Subscribe To Our Newsletter & Stay Updated
